[{"NetIncomeLossConverted_3_Q3_USD":837001000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":194959000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":197674000.0,"CommonStockSharesConverted_0_Q3_shares":181492344.0,"Assets_0_Q3_USD":6158090000.0,"RevenuesConverted_3_Q3_USD":1408338000.0,"RevenuesConverted_1_Q3_USD":476784000.0,"EarningsPerShareBasic_1_Q3_USD":4.33,"StockholdersEquity_0_Q3_USD":4053893000.0,"EarningsPerShareDiluted_3_Q3_USD":4.39,"EarningsPerShareDiluted_1_Q3_USD":4.01,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":98749000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":180592000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":181142000.0,"NetIncomeLossConverted_1_Q3_USD":784803000.0,"CommonStockSharesOutstanding_0_Q3_shares":181492344.0,"EarningsPerShareBasic_3_Q3_USD":4.63,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]